JP2014521605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521605A5 JP2014521605A5 JP2014521610A JP2014521610A JP2014521605A5 JP 2014521605 A5 JP2014521605 A5 JP 2014521605A5 JP 2014521610 A JP2014521610 A JP 2014521610A JP 2014521610 A JP2014521610 A JP 2014521610A JP 2014521605 A5 JP2014521605 A5 JP 2014521605A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- item
- als3p
- candida
- vaccine according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161510896P | 2011-07-22 | 2011-07-22 | |
| US61/510,896 | 2011-07-22 | ||
| PCT/US2012/000328 WO2013015831A1 (en) | 2011-07-22 | 2012-07-20 | Methods and compositions for vaccinating against staphylococcus aureus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014521605A JP2014521605A (ja) | 2014-08-28 |
| JP2014521605A5 true JP2014521605A5 (enExample) | 2015-08-27 |
Family
ID=47601425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014521610A Pending JP2014521605A (ja) | 2011-07-22 | 2012-07-20 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓに対してワクチン接種するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10653757B2 (enExample) |
| EP (1) | EP2734229B1 (enExample) |
| JP (1) | JP2014521605A (enExample) |
| CN (1) | CN103998056B (enExample) |
| AU (1) | AU2012287513A1 (enExample) |
| BR (1) | BR112014001409A2 (enExample) |
| CA (1) | CA2842626A1 (enExample) |
| EA (1) | EA035513B1 (enExample) |
| ES (1) | ES2716800T3 (enExample) |
| GE (1) | GEP201706766B (enExample) |
| UA (1) | UA114286C2 (enExample) |
| WO (1) | WO2013015831A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| AU2012287513A1 (en) | 2011-07-22 | 2014-03-13 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Methods and compositions for vaccinating against Staphylococcus aureus |
| US20160030443A1 (en) * | 2013-03-14 | 2016-02-04 | Rongfu Wang | Methods and compositions for modulating regulatory t cell function |
| WO2014153241A1 (en) * | 2013-03-14 | 2014-09-25 | The Regents Of The University Of Michigan | Treatment of staphylococcal disorders |
| AU2014227748B2 (en) * | 2013-03-15 | 2019-02-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for treating fungal and bacterial pathogens |
| JP2019507759A (ja) * | 2016-03-09 | 2019-03-22 | ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター | 外陰部膣カンジダ症の予防及び治療で使用するための方法及びキット |
| CN105713096B (zh) * | 2016-03-29 | 2019-01-01 | 黑龙江八一农垦大学 | 一种预防金黄色葡萄球菌感染的att融合蛋白的制备及应用 |
| US12163135B2 (en) | 2017-12-05 | 2024-12-10 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
| JP7439371B2 (ja) | 2018-04-10 | 2024-02-28 | ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー－ ユーシーエルエー メディカル センター | Ｃａｎｄｉｄａ ａｕｒｉｓ感染症の治療方法 |
| CN112940987B (zh) * | 2021-04-10 | 2022-10-14 | 福建省农业科学院畜牧兽医研究所 | 一株兔金黄色葡萄球菌及其在制备灭活疫苗中的应用 |
| US20220354935A1 (en) * | 2021-04-21 | 2022-11-10 | Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center | Vaccination against fungal epitopes to prevent inflammatory bowel diseases |
| WO2025032534A2 (en) * | 2023-08-09 | 2025-02-13 | Glaxosmithkline Biologicals Sa | Modified proteins |
| WO2025240443A1 (en) * | 2024-05-14 | 2025-11-20 | University Of Rochester | Candida for use in prevention or mitigation of cutaneous viral infections |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980000412A1 (en) | 1978-08-24 | 1980-03-20 | N Gilmour | Pasteurellosis vaccines |
| US5622939A (en) | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
| CA2134773A1 (en) | 1992-06-04 | 1993-12-09 | Robert J. Debs | Methods and compositions for in vivo gene therapy |
| JPH09500013A (ja) | 1993-06-01 | 1997-01-07 | ライフ・テクノロジーズ・インコーポレイテッド | カチオン性脂質による遺伝子免疫 |
| US5961970A (en) | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
| AU2657495A (en) | 1994-05-23 | 1995-12-18 | Research And Development Institute, Inc. | Candida albicans adhesin as a vaccine |
| US5668263A (en) | 1994-12-16 | 1997-09-16 | Smithkline Beecham Corporation | Conserved yeast nucleic acid sequences |
| DK0831897T3 (da) | 1995-06-07 | 2001-04-30 | Pfizer | In ovo-vaccination mod coccidiosis |
| EP0950068B1 (en) | 1996-05-16 | 2005-11-09 | THE TEXAS A&M UNIVERSITY SYSTEM | Collagen binding protein compositions and methods of use |
| US6747137B1 (en) | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
| US6248329B1 (en) | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| US6703025B1 (en) | 1998-08-31 | 2004-03-09 | Inhibitex, Inc. | Multicomponent vaccines |
| US7067138B1 (en) | 1999-11-19 | 2006-06-27 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| US8541008B2 (en) * | 1999-11-19 | 2013-09-24 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against candidiasis |
| US20060083750A1 (en) | 1999-11-19 | 2006-04-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| EP3269235B1 (en) | 2001-11-30 | 2022-01-26 | Amgen Fremont Inc. | Transgenic mice bearing human ig lambda light chain genes |
| CN100528225C (zh) | 2002-05-21 | 2009-08-19 | 先灵-普劳有限公司 | 孢子纲物种体外培养的方法及其用途 |
| US7241613B1 (en) | 2002-06-05 | 2007-07-10 | Oscient Pharmaceuticals Corporation | Identification of Candida cell surface proteins and their uses |
| WO2004043407A2 (en) | 2002-11-12 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Methods and products for treating staphylococcal infections |
| CN1882360A (zh) | 2003-11-21 | 2006-12-20 | 辉瑞产品公司 | 抗生素作为疫苗佐剂的用途 |
| US20050287146A1 (en) | 2003-12-19 | 2005-12-29 | Joseph Patti | Method of inhibiting Candida-related infections using donor selected or donor stimulated immunoglobulin compositions |
| GB0420466D0 (en) | 2004-09-14 | 2004-10-20 | Cassone Antonio | Anti-glucan antibodies |
| WO2006036817A2 (en) | 2004-09-24 | 2006-04-06 | Microbia, Inc. | Fungal variants and uses thereof |
| CA2489194A1 (en) | 2004-12-03 | 2006-06-03 | Guilhem Janbon | Polypeptides involved in candida biofilm formation and uses thereof |
| WO2007126813A2 (en) | 2006-03-29 | 2007-11-08 | Inhibitex, Inc. | Cross-reactive monoclonal antibodies recognizing als family proteins |
| MX2008013451A (es) | 2006-04-17 | 2008-10-30 | Schering Plough Ltd | Organismos clostridium atenuados recombinantes y vacuna. |
| US20080311135A1 (en) | 2007-05-22 | 2008-12-18 | Baylor College Of Medicine | Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations |
| EP2039764A1 (en) * | 2007-09-19 | 2009-03-25 | Pevion Biotech AG | Truncated secretory aspartyl proteinase 2 |
| MX2010012869A (es) | 2008-05-29 | 2010-12-14 | Intervet Int Bv | Vacunas contra coccidiosis. |
| US20100150942A1 (en) | 2008-12-03 | 2010-06-17 | Cantor Thomas L | Affinity purified human polyclonal antibodies and methods of making and using them |
| BRPI1015567A2 (pt) * | 2009-06-22 | 2021-08-31 | Wyeth Llc | Composições imunogênicas de antígenos de staphylococcus aureus |
| RU2559537C2 (ru) | 2009-07-03 | 2015-08-10 | Лос-Анджелес Биомедикал Ресерч Институт Эт Харбор-Укла Медикал Центер | Hyr1 в качестве мишени для активной и пассивной иммунизации против candida |
| WO2012163533A1 (en) | 2011-06-01 | 2012-12-06 | Eth Zurich | T cell epitope of candida albicans |
| AU2012287513A1 (en) | 2011-07-22 | 2014-03-13 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Methods and compositions for vaccinating against Staphylococcus aureus |
| GB201503812D0 (en) | 2015-03-06 | 2015-04-22 | Univ Aberdeen | Antibody molecules and uses thereof |
| JP2019507759A (ja) | 2016-03-09 | 2019-03-22 | ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター | 外陰部膣カンジダ症の予防及び治療で使用するための方法及びキット |
-
2012
- 2012-07-20 AU AU2012287513A patent/AU2012287513A1/en not_active Abandoned
- 2012-07-20 BR BR112014001409A patent/BR112014001409A2/pt not_active IP Right Cessation
- 2012-07-20 EP EP12817530.4A patent/EP2734229B1/en not_active Not-in-force
- 2012-07-20 GE GEAP201213225A patent/GEP201706766B/en unknown
- 2012-07-20 UA UAA201310981A patent/UA114286C2/uk unknown
- 2012-07-20 CA CA2842626A patent/CA2842626A1/en active Pending
- 2012-07-20 US US14/234,269 patent/US10653757B2/en active Active
- 2012-07-20 JP JP2014521610A patent/JP2014521605A/ja active Pending
- 2012-07-20 ES ES12817530T patent/ES2716800T3/es active Active
- 2012-07-20 EA EA201391200A patent/EA035513B1/ru not_active IP Right Cessation
- 2012-07-20 CN CN201280046321.4A patent/CN103998056B/zh not_active Expired - Fee Related
- 2012-07-20 WO PCT/US2012/000328 patent/WO2013015831A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014521605A5 (enExample) | ||
| US8980275B2 (en) | Targeted heterologous antigen presentation on calicivirus virus-like particles | |
| MX2023000411A (es) | Vacuna combinada de sars-cov-2 e influenza. | |
| CN113666990B (zh) | 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用 | |
| JP2015214545A5 (enExample) | ||
| SI2280721T1 (en) | Indoleamine 2, 3-dioxygenase based immunotherapy | |
| JP2014534202A5 (enExample) | ||
| NZ612315A (en) | Compositions for immunising against staphylococcus aureus | |
| IL276210B2 (en) | Mers-cov vaccine | |
| JP2009539965A5 (enExample) | ||
| ES2642892T3 (es) | Protección de vacuna multivalente contra la infección por estafilococo aureus | |
| JP2015500827A5 (enExample) | ||
| JP2015529677A5 (enExample) | ||
| JP2014519817A5 (enExample) | ||
| JP5661744B2 (ja) | 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用 | |
| WO2011112906A3 (en) | Novel immunogens and methods for discovery and screening thereof | |
| Isakova-Sivak et al. | The future of haemagglutinin stalk-based universal influenza vaccines | |
| KR20150020164A (ko) | 보강제 제형 및 방법 | |
| CN102000330B (zh) | 一种核酸疫苗佐剂及其构建方法 | |
| CA2795308A1 (en) | Parapoxvirus expressing the vp60 major capsid protein of the rabbit haemorrhagic disease virus | |
| CO6300795A2 (es) | Un vector adenovirico de simio para uso en una vacuna | |
| KR20180080178A (ko) | 세균성 백신 및 바이러스성 백신 방법 | |
| CN102038951B (zh) | 基于mcp-1设计的核酸疫苗佐剂及其构建方法 | |
| NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella | |
| GB2599572A (en) | Compositions and methods of manufacturing trivalent filovirus vaccines |